Glassman Wealth Services’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
DG
Glassman Wealth Services's HCAT Position: Q4 2022 in Review
Glassman Wealth Services sold out of Health Catalyst (HCAT) in Q4 2022, closing a stake of 60 shares — an estimated $1K sold.
Glassman Wealth Services first reported a position in HCAT in Q2 2022 and held it in 2 quarters. The position peaked at $2K in Q2 2022. 166 funds tracked by Wall St. Rank hold HCAT as of Q4 2022.
- Glassman Wealth Services reported no remaining Health Catalyst position as of Q4 2022 after selling out during the quarter.
- Glassman Wealth Services sold 60 Health Catalyst shares in Q4 2022, an estimated $1K.
- Glassman Wealth Services first reported a position in Health Catalyst in Q2 2022 and held it in 2 quarters.
- Glassman Wealth Services's Health Catalyst position peaked at $2K in Q2 2022.
- 166 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2022.
Based on Glassman Wealth Services's 13F filing for Q4 2022, filed 6 Feb 2023.